Hippeläinen E - Search Results

1

Seasonal Temperature Changes Do Not Affect Cardiac Glucose Metabolism.

Schildt J, Loimaala A, Hippeläinen E, Nikkinen P, Ahonen A. Schildt J, et al. Among authors: hippelainen e. Int J Mol Imaging. 2015;2015:916016. doi: 10.1155/2015/916016. Epub 2015 Dec 29. Int J Mol Imaging. 2015. PMID: 26858844 Free PMC article.

2

Personal radiation doses in PET/CT facility: measurements vs. calculations.

Hippeläinen E, Nikkinen P, Ihalainen T, Uusi-Simola J, Savolainen S. Hippeläinen E, et al. Radiat Prot Dosimetry. 2008;132(1):57-63. doi: 10.1093/rpd/ncn213. Epub 2008 Aug 19. Radiat Prot Dosimetry. 2008. PMID: 18713782

3

Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients.

Schildt JV, Loimaala AJ, Hippeläinen ET, Ahonen AA. Schildt JV, et al. Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):293-298. doi: 10.1093/ehjci/jex175. Eur Heart J Cardiovasc Imaging. 2018. PMID: 28950301

4

Convolutional neural networks for detection of transthyretin amyloidosis in 2D scintigraphy images.

Halme HL, Ihalainen T, Suomalainen O, Loimaala A, Mätzke S, Uusitalo V, Sipilä O, Hippeläinen E. Halme HL, et al. Among authors: hippelainen e. EJNMMI Res. 2022 May 7;12(1):27. doi: 10.1186/s13550-022-00897-9. EJNMMI Res. 2022. PMID: 35524861 Free PMC article.

5

Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry.

Gabiña PM, Gleisner KS, Cremonesi M, Stokke C, Flux G, Cicone F, Konijnenberg M, Aldridge M, Sandstrom M, Chiesa C, Paphiti M, Hippeläinen E, Uribe C, Solny P, Gnesin S, Bernhardt P, Chouin N, Costa PF, Glatting G, Verburg F, Gear J. Gabiña PM, et al. Among authors: hippelainen e. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2595-2604. doi: 10.1007/s00259-023-06215-2. Eur J Nucl Med Mol Imaging. 2023. PMID: 37129712 No abstract available.

6

Intravitreal Pharmacokinetics in Mice: SPECT/CT Imaging and Scaling to Rabbits and Humans.

Schmitt M, Hippeläinen E, Raviña M, Arango-Gonzalez B, Antopolsky M, Vellonen KS, Airaksinen AJ, Urtti A. Schmitt M, et al. Among authors: hippelainen e. Mol Pharm. 2019 Oct 7;16(10):4399-4404. doi: 10.1021/acs.molpharmaceut.9b00679. Epub 2019 Sep 3. Mol Pharm. 2019. PMID: 31430156

7

Adenosine-induced splenic switch-off on [¹⁵O]H₂O PET perfusion for the assessment of vascular vasodilatation.

Inkinen SI, Hippeläinen E, Uusitalo V. Inkinen SI, et al. Among authors: hippelainen e. EJNMMI Res. 2023 Nov 9;13(1):96. doi: 10.1186/s13550-023-01045-7. EJNMMI Res. 2023. PMID: 37943363 Free PMC article.

8

[No title available]

[No authors listed] [No authors listed] PMID: 32568778

9

Assessment of ejection fraction and heart perfusion using myocardial perfusion single-photon emission computed tomography in Finland and Estonia: a multicenter phantom study.

Ronkainen AP, Eneh CTM, Linder PH, Hippeläinen E, Heikkinen JO. Ronkainen AP, et al. Among authors: hippelainen e. Nucl Med Commun. 2020 Sep;41(9):888-895. doi: 10.1097/MNM.0000000000001234. Nucl Med Commun. 2020. PMID: 32796477

10

Effect of calculation method on kidney dosimetry in ¹⁷⁷Lu-octreotate treatment.

Heikkonen J, Mäenpää H, Hippeläinen E, Reijonen V, Tenhunen M. Heikkonen J, et al. Among authors: hippelainen e. Acta Oncol. 2016 Sep-Oct;55(9-10):1069-1076. doi: 10.1080/0284186X.2016.1182642. Epub 2016 May 24. Acta Oncol. 2016. PMID: 27219529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters